GlassScriptPhysician profile
Ryan Furdock
NPI 1114553104
$7,752.47
in general payments reported to CMS, 2019-2025
7 companies · $4,684 in 2025
The $4,684 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,211 · 2023: $270 · 2024: $1,587 · 2025: $4,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,712 · Food and Beverage: $2,829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,711.62 |
| Food and Beverage | $2,829.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,830.29 | 2025 | Velys, Na |
| Stryker Corporation | $2,322.46 | 2023-2025 | Pro, Mako, Aequalis Perform |
| Rock Medical Orthopedics, INC. | $1,211.45 | 2022 | |
| Depuy Synthes Sales INC. | $220.38 | 2024 | Na, Va-Lcp |
| Orthalign INC | $107.59 | 2025 | Orthalign Plus |
| Axogen | $38.22 | 2025 | |
| Zimmer Biomet Holdings, INC. | $22.08 | 2025 | Osseofit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Furdock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.